Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996)

Journal of the American Veterinary Medical Association

Volumn 217, Issue 1, 2000, Pages 68-73

  Stratton Phelps, Meri ^a   Wilson, W David ^a   Gardner, Ian A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PROCAINE PENICILLIN; RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG INDUCED DISEASE; FEMALE; HORSE; HYPERTHERMIA; MALE; NONHUMAN; PATHOGENESIS; PNEUMONIA; RESPIRATORY DISTRESS; RISK ASSESSMENT;

ANIMALIA; EQUUS CABALLUS;

EID: 0034235425     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2000.217.68     Document Type: Article

References (36)

1. Sande MA, Mandell GL. Antimicrobial agents. In: Gilman AG, Rall TW, Nies AS, et al, eds. The pharmacological basis of therapeutics. 8th ed. New York: McGraw-Hill Book Co Inc, 1993;1130-1134.
2. Prescott JF, Hoffman AM. Rhodococcus equi. Vet Clin North Am Equine Pract 1993;9:375-384.
3. Sweeney CR, Sweeney RW, Divers TJ. Rhodicoccus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Microbiol 1987;14:329-336.
4. Burrows GE, MacAllister CG, Beckstrom DA, et al. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations. Am J Vet Res 1985;46:442-446.
5. Prescott JF, Hoover DJ, Dohoo IR. Pharmacokinetics of erythromycin in foals and in adult horses. J Vet Pharmacol Ther 1983; 6:67-74.
6. Prescott JF, Sweeney CR. Treatment of Corynebacterium equi pneumonia of foals: a review. J Am Vet Med Assoc 1985;187:725-728.
7. Wilson WD. Foal pneumonia. In: Robinson NE, ed. Current therapy in equine medecine III. Philadelphia: WB Saunders Co, 1992; 466-473.
8. Gustafsson A, Baverud V, Gunnarsson A, et al. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J 1997;24:314-318.
9. Traub-Dargatz J, Wilson WD, Conboy HS, et al. Hyperthermia in foals treated with erythromycin alone or in combination with rifampin for respiratory disease during hot environmental conditions, in Proceedings. Am Assoc Equine Pract 1996;42: 243-244.
10. Chaffin MK, Martens RJ. Extrapulmonary disorders associated with Rhodococcus equi pneumonia in foals: retrospective study of 61 cases (1988-1996), in Proceedings. Am Assoc Equine Pract 1997;43:79-80.
11. Lakritz J, Wilson WD. Erythromycin: pharmacokinetics, bioavailability, nonantimicrobial activity, and possible mechanisms associated with adverse reactions, in Proceedings. Am Assoc Equine Pract 1997;43:83-86.
12. Lakritz J, Wilson WD, Watson JL, et al. Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals. Am J Vet Res 1997;58:56-61.
13. Lakritz J, Wilson WD, Berry CR, et al. Bronchointerstitial pneumonia and respiratory distress in young horses: clinical, clinical pathologic., radiographic, and pathological findings in 23 cases (1984-1989). J Vet Intern Med 1993;7:277-288.
14. Prescott JF, Baggot JD. Lincosamides and macrolides. In: Antimicrobial therapy in veterinary medicine. Boston: Blackwell Scientific Publications, 1988;167.
15. Hillidge CJ. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet Microbiol 1987;14: 337-342.
16. Rothman KJ. Modern epidemiology. Boston: Little, Brown and Co, 1986;172.
17. Holst JJ, Schmidt P. Gut hormones and intestinal function. Baillieres Clin Endrocrinol Metabol 1994;8:137-164.
18. Peeters T, Matthijs G, Depoortere I, et al. Erythromycin is a motilin receptor agonist. Am J Physiol 1989;257:G470-G474.
19. Tomomasa T, Kuroume T, Arai H, et al. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157-161.
20. Lester GD, Merritt AM, Neuwirth L, et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. Am J Vet Res 1998;59:328-334.
21. Costa A, De Ponti F, Gibelli G, et al. In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit. Pharmacology 1997;54:64-75.
22. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Gastroenterol Clin North Am 1996; 25:225-246.
23. Ringger NC, Lester GD, Neuwirth L, et al. Effect of bethanechol or erythromycin on gastric emptying in horses. Am J Vet Res 1996;57:1771-1775.
24. Hasler WL, Heldsinger A, Owyang C. Erythromycin contracts rabbit colon myocytes via occupation of motilin receptors. Am J Physiol 1992;262:G50-G55.
25. Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol 1990;259:G355-G363.
26. Itoh Z, Suzuki T, Nakaya M, et al. Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. Antimicrob Agents Chemother 1984; 26:863-869.
27. Baverud V, Gustafsson A, Franklin A, et al. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J 1997;29:279-284.
28. Murray MJ. Acute colitis. In: Robinson NE, ed. Current therapy in equine mediant IV. Philadelphia: WB Saunders Co, 1997; 197-203.
29. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993;88:203-207.
30. Lakritz J, Wilson WD, Mihalyi JE. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am J Vet Res 1999;60:414-419.
31. Lakritz J, Wilson WD, Marsh AE, et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to fasted foals. Am J Vet Res 2000;in press.
32. Lakritz J, Wilson WD, Marsh AE. et al. Effects of prior feeding on the single dose pharmacokinetics and estimated bioavailability of microencapsulated erythromycin base (MEB) in healthy foals. Am J Vet Res 2000;in press.
33. Giguere S, Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997;56:313-334.
34. Villagrasa V, Berto L, Cortijo J, et al. Effects of erythromycin on chemoattractant-activated human polymorphonuclear leukocytes. Gen Pharmacol 1997;29:605-609.
35. Nelson S, Summer WR, Terry PB. et al Erythromycin-induced suppression of pulmonary antibacterial defenses: a potential mechanism of superinfection in the lung. Am Rev Respir Dis 1987; 130:1107-1212.
36. Ainsworth DM, Weldon AD, Beck KA. et al. Recognition of Pneumocystis carinii in foals with respiratory disease. Equine Vet J 1993;25:103-108.